PRP18, a protein required for the second reaction in pre-mRNA splicing by Vijayraghavan, Usha & Abelson, John
Vol. 10, No. 1MOLECULAR AND CELLULAR BIOLOGY, Jan. 1990, p. 324-332
0270-7306/90/010324-09$02.00/0
Copyright © 1990, American Society for Microbiology
PRP18, a Protein Required for the Second Reaction
in Pre-mRNA Splicing
USHA VIJAYRAGHAVAN AND JOHN ABELSON*
Division ofBiology 147-75, California Institute of Technology, Pasadena, California 91125
Received 25 July 1989/Accepted 12 October 1989
We have investigated the role of a novel temperature-sensitive splicing mutation, prpl8. We had previously
demonstrated that an accumulation of the lariat intermediate of splicing occurred at the restrictive temperature
in vivo. We have now used the yeast in vitro splicing system to show that extracts from this mutant strain are
heat labile for the second reaction of splicing. The heat inactivation ofprpl8 extracts results from loss of activity
of an exchangeable component. Inactivated prpl8 extracts are complemented by heat-inactivated extracts from
other mutants or by fractions from wild-type extracts. In heat-inactivated prpl8 extracts, 40S splicing
complexes containing lariat intermediate and exon 1 can assemble. The intermediates in this 40S complex can
be chased to products by complementing extracts in the presence of ATP. Both complementation of extracts
and chasing of the isolated prpl8 spliceosomes takes place with micrococcal nuclease-treated extracts.
Furthermore, the complementation profile with fractions of wild-type extracts indicates that the splicing defect
results from a mutation in a previously designated factor required for the second step of splicing. The isolation
of this mutant as temperature-sensitive lethal has also facilitated cloning of the wild-type allele by complemen-
tation.
The recognition and splice site selection in nuclear pre-
mRNA splicing is dictated by three short stretches of se-
quence elements in the intron (34). The specificity of splice
junction selection and the juxtaposition of the exons is
achieved by the recognition of these cis-acting conserved
elements in the intron by cellular factors that include pro-
teins and small nuclear ribonucleoprotein particles (snRNPs)
(reviewed in references 28 and 35). The pre-mRNA is spliced
in a large multicomponent structure termed the spliceosome
(2, 5, 10, 11, 30). Splicing reactions that take place in the
spliceosome occur via a two-step mechanism. First, the
pre-mRNA is cleaved at the 5' splice junction, and this
results in the formation of the reaction intermediates: exon 1
and a lariat intron-exon 2 structure in which the first base of
the intron is covalently linked to a specific adenosine near
the 3' splice site. The second reaction involves cleavage at
the 3' splice site and the ligation of the two exons to produce
the mature mRNA and the lariat intron (for reviews, see
references 12 and 29).
The complexity of the splicing reaction and the large
particle in which the reactions take place suggests the need
for multiple functions. At least five small nuclear RNAs
(snRNAs) (Ul, U2, U4, U5, and U6) are involved in the
splicing of both yeast and higher eucaryotic pre-mRNA (13,
38). These snRNAs, functioning in the form of snRNPs, are
associated with active splicing complexes. The spliceosome
assembly intermediates resolved on nondenaturing gels vary
in the order of appearance and their snRNP composition. Ul
binds to the pre-mRNA first, and this is followed by the
binding of U2, U4, U5, and U6 snRNPs (3, 8, 16, 31, 32). The
requirement in splicing for protein factors, apart from sn-
RNPs, has been demonstrated through biochemical fraction-
ation of splicing extracts (7, 18, 19).
Analysis of splicing factors in Saccharomyces cerevisiae
can readily use a combination of biochemical, classical
genetic, and molecular approaches. Such an approach has
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taken advantage of a set of temperature-sensitive mutations
(rna2 to rnall) that affect pre-mRNA splicing in vivo for the
analysis of splicing factors (for reviews, see references 40
and 42). Henceforth, all the rna mutants will be called
pre-RNA processing (prp) mutants. In vitro heat inactivation
of splicing extracts from many of these prp complementation
groups has implied a direct role for these gene products in
pre-mRNA splicing. Consistent with the in vivo observation
of pre-mRNA accumulation at nonpermissive temperatures
in all of the prp2 to prpll strains, inactivation of both steps
of splicing was observed upon heating of splicing extracts
from most of the mutants (26). In addition, most of the PRP
gene products are required for spliceosome formation itself
(23). The exception is the PRP2 gene product, which acts
after spliceosome assembly and is required for the first
splicing reaction. Studies on the role of PRP2 in in vitro
splicing systems have suggested the need for several extrin-
sic and intrinsic factors for both splicing reactions (23). In
addition to the in vitro characterization of the prp2 to prpll
mutants, many of these genes have been cloned and their
molecular characterization has been initiated (15, 20-22, 37;
for a review, see reference 40). Antibodies directed against
PRP4, PRP8, and PRP11 proteins inhibit the in vitro splicing
reaction, reaffirming their essential role in splicing (1, 6, 15).
The PRP8 protein has been demonstrated to associate with
U5 snRNA (25). The association of the PRP4 protein with
the U4/U6 snRNAs has recently been shown (1). The PRP11
protein associates with spliceosomes and is also present in a
preassembled 30S complex.
We have recently isolated a new set of temperature-
sensitive mutations affecting pre-mRNA processing (41).
Isolation of these 11 new complementation groups affecting
pre-mRNA splicing in vivo was done by a direct search for
such mutants. Interestingly, four groups with novel pheno-
types were obtained which specifically affected late stages of
splicing: (i) cleavage at the 3' splice site and exon ligation
and (ii) degradation of the lariat intron. These mutants
facilitate the development of assays for specific steps in
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splicing, and therefore the analysis and purification of spe-
cific splicing factors. The isolation of two complementation
groups (prpl7 and prp18) with the phenotype of lariat
intermediate accumulation allows analysis of splicing com-
ponents required for the second reaction of splicing. In these
mutants, the lariat accumulation results from a specific
defect affecting the second splicing reaction, as no pre-
mRNA accumulates at the nonpermissive temperature.
Studies on the prp2 heat-inactivated spliceosomes have
suggested the requirement for two sets of factors for the
second splicing reaction (23). In mammalian systems also, at
least two factors have been reported to be required at this
stage of splicing (18, 19).
A combination of biochemical and molecular analyses has
been initiated to study the role of PRP18 in splicing. We
report that a mutation in one of the previously hypothesized
S. cerevisiae splicing factors results in lariat intermediate
accumulation. A specific requirement for ATP in the second
step of splicing was also observed. We also report the
cloning of the wild-type PRP18 locus.
MATERIALS AND METHODS
Strains and microbiological techniques. The wild-type S.
cerevisiae strains used in this study were EJ101 and SS330.
The prpS strain was RL172, and the prpll strain was
SPJ11.4. The genotypes of these strains are as described by
Lustig et al. (26) and Vijayraghavan et al. (41). The prpl8-2
strains were obtained after outcrossing temperature-sensi-
tive (ts) strain 503 with wild-type strain SS330 and were
503-la MATa ade2-101 his3A200 ura3-52 lys2-801 and 503-6c
MATa ade2-101 his3A200 ura3-52 lys2-801. The yeast strains
were propagated by standard methods on media as described
by Sherman et al. (36). Temperature-sensitive strains were
maintained at 23°C, and 37°C was used as the nonpermissive
temperature. Sporulation, omission, and preparation of rich
media were done as described by Sherman et al. (36). Yeast
transformations were all done by the lithium acetate proce-
dure of Ito et al. (14). Transformants were selected on
omission media at 23°C, and colonies were then replica
plated to prewarmed rich plates (YPD) at 37°C to test for
temperature resistance. The YCp50-based Sau3A library of
S. cerevisiae genomic DNA was obtained from M. Rose and
P. Novick. The yeast shuttle vectors pPHY18 (CEN ARS
URA3 Ampr) and pSEY18 (2p.m ARS URA3 Ampr) used in
subcloning experiments were kindly provided by P. Herman
and S. Emr. Selection for the loss of yeast CEN URA3
plasmids was done on 5-fluoro-orotic acid plates prepared as
described by Boeke et al. (4). The Escherichia coli strain
used for cloning and DNA amplification was MC1061 [F-
araD139 A(araABIOC-leu)7679 A(lac) X74 galU galK rpsL
hsr hsm+].
Nucleic acid manipulations. Restriction mapping and stan-
dard cloning techniques were done essentially as described
by Maniatis et al. (27). Subcloning of restriction fragments
from the plasmids was done after isolation of the desired
restriction fragment and of the suitably digested vectors
(pPHY18, pSEY18, or YIP5) from low-melting-point agarose
gels. The plasmids from E. coli cells were analyzed after
alkali lysis preparation of DNA. Probes, when used, were
restriction fragments obtained from low-melting-point agar-
ose gels and were generated with the random primer-labeling
procedure of Feinberg and Vogelstein (9). Small-scale prep-
arations of yeast genomic DNA were done as described by
Sherman et al. (36). Southern blots were performed as
suggested by Dupont, NEN Research Products. Hybridiza-
tions were conducted in conditions similar to those de-
scribed by Cheng and Abelson (8).
Preparation of total RNA from yeast was done as de-
scribed by Vijayraghavan et al. (41). The RNA was sepa-
rated on formaldehyde-agarose gels before being blotted
onto a nylon membrane. Primer extension on 20 ,ug of total
RNA, with an RP51 oligonucleotide hybridizing 70 nucleo-
tides downstream of the 5' splice site as a primer, was
performed with reverse transcriptase as described by Vijay-
raghavan et al. (41).
Preparation of splicing extracts. Extracts were isolated
from mid- to late-logarithmic-phase cells grown in YPD at
23°C by the spheroplast procedure of Lin et al. (24). The
protein concentration of the extracts was approximately 20
mg/ml. Fractions 40P3 and 40W from extracts of wild-type
EJ101 cells were provided by S.-C. Cheng.
In vitro splicing reactions, heat inactivation, and comple-
mentation. SP6 actin transcripts were generated by using
SP6 polymerase with UTP at 100 ,uM and [32P]UTP at 2
mCi/ml. Heat inactivation of splicing extracts involved the
use of 7 p.l of extract to which was added 2.2 .l of an
inactivation cocktail such that inactivation conditions were
2.4 mM MgCl2-1 mM dithiothreitol-12 U of RNasin. Inacti-
vation was done at 30 to 32°C for various periods, and time
point samples were taken and kept on ice until completion of
the last time point, at which time splicing was initiated.
Splicing cocktail was added to obtain a final concentration of
2.2 mM ATP-55 mM KPO4-2.7% polyethylene glycol, with
5,000 to 10,000 cpm (-3.3 fmol) of labeled actin pre-mRNA.
Splicing was carried out at 15°C for 30 to 60 min, and the
reaction mixture was phenol extracted and ethanol precip-
itated. The precipitated RNA was analyzed on denaturing
polyacrylamide gels as described by Lin et al. (24). Comple-
mentation in vitro was tested by mixing approximately equal
amounts of individually inactivated extracts before initiation
of splicing. Fractions of wild-type extract were diluted in
inactivation cocktail and were then added to inactivated
prpl8 extracts.
Glycerol gradient sedimentation of splicing reactions. Splic-
ing reaction mixtures (50 ,lI) were chilled on ice and diluted
with cold gradient buffer (0.1 M KCl-2 mM MgCl2-20 mM
HEPES [N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic
acid], pH 7.4) such that the density of the sample was lower
than that of the top of the gradient. The diluted sample was
layered carefully on a 15 to 27% glycerol gradient made in
0.5- to 2-inch (1.3- to 5-cm) polyallomer tubes. The sedimen-
tation was done at 50,000 rpm for about 100 min at 2 to 4°C
in an SW55 rotor. Fractions were collected on ice, and
Cerenkov counts of the fractions were determined. Frac-
tions of interest were frozen in liquid N2 and stored at
-70°C. A small sample from each fraction across the 40S
region of the gradient was phenol extracted and ethanol
precipitated. The samples were analyzed on nondenaturing
gels to confirm that the 40S region contained the expected
labeled RNA molecules.
Chasing reaction of gradient-isolated spliceosomes. Conver-
sion of the lariat intermediate and exon 1 to products (lariat
intron and mRNA) was termed a chasing reaction. Typically,
20-,ul reaction mixtures with 14 p.1 of the appropriate gradient
fraction, 1 p.1 of lOx chasing buffer (200 mM KPO4, pH 7, 11
mM MgCl2, 20 mM ATP, 14% polyethylene glycol 8000) and
2 p.1 of complementing extract were incubated at 15°C for 60
min. Fractions of wild-type extract when used for comple-
mentation were added at one-half the volume of other
complementing extracts. The reaction products were recov-
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ature (15°C for 60 min). In extracts from prp18, lariat
intermediate and exon 1 accumulated and there was a
substantial decrease in the levels of the mRNA and the lariat
intron after 60 min of heat inactivation (Fig. 1B). The lack of
d_w - an increase in the lariat intermediate and exon 1 levels with
:'VS-6.fS*'_2 ___ increasing preincubation time is most likely due to a nonspe-
s- . YS- cific decrease in total splicing activity upon prolonged pre-
- ,,e-mRNA zree-NA-_A incubation. Some wild-type extracts also exhibited a de-
crease in total splicing activity upon preincubation for a
P
r w
-Asimilar period (26; data not shown). It is possible that PRP18
- -mRNA has a secondary effect on early events of splicing, and this
may account for the decrease in splicing efficiency with
preincubation at 30°C. However, this is unlikely to be the
primary function of this splicing factor, since no detectable
effect on early events in splicing, i.e., accumulation of
pre-mRNA, was discernible in vivo (41).
In vitro complementation of inactivated extracts. Splicing
assays with extracts prepared from prpl8 strains accumu-
lated lariat intermediate and exon 1. One possible reason for
this effect is denaturation or inactivation of a specific splicing
component as a result of temperature sensitivity of the
protein or RNA. To substantiate this theory, inactivated
cing activity in prpl8 and wild-type extracts. prpl8 extracts were used to complement inactivated extracts
conducted at 15°C for 30 or 60 min as indicated. from other temperature-sensitive strains. Complete inactiva-
Prp18 strains (ts 503-la and ts 503-6c) and from tion of extracts from prpS or prpl 1 strains was obtained as
SS330 were assayed. These extracts were used previously described (26). Mixing of inactivated prpl8 ex-
activation, with splicing conditions as described previously dscribed (26) Mi ofinactivatedpp ex-
thods. Migration positions of the lariat interme- tract with inactivated prpS or prpll extract resulted in some
lariat intron (IVS*), spliced exons(mRNA),and restoration of splicing activity (Fig. 2, lanes 1 and 2). A
cated. (B) Heat inactivation of splicing extracts slightly higher level of complementation was achieved with
c extracts were inactivated under the conditions inactivated prpll extract than with inactivated prpS extract.
als and Methods for increasing periods of time (0 However, it is difficult to make a direct comparison because
kfter inactivation, splicing was initiated with the of the different splicing activities of prpS and prpll extracts
actin pre-mRNA in a cocktail, and splicing was themselves. A combination of ts 503-6c extract with inacti-
or 60 min. Reaction products were fractionated vated extracts from cells bearing the same prpl8 mutation in
amide gels. RNA species labeled IVS*E2, IVS*, a different genetic background did not result in complemen-
and El are explained above. tation (Fig. 2, lane 6). Thus, the loss of activity is due, at
least in part, to inactivation of the PRP18 gene product; the
loroform extraction and were separated on complementation also indicates that some of the splicing
els. factors can exchange under these assay conditions.
The defect in heat-inactivated prpl8 extracts can also be
RESULTS complemented with fractions from a wild-type extract. Wehave used fraction I (40P3) and fractions II plus III (40W)
[on of splicing extracts from prpl8. The obtained by ammonium sulfate precipitation (7). Comple-
nperature-sensitive mutation affecting the mentation of the prpl8 splicing defect is striking with 40P3
licing in vivo provides a route for the study (fraction I) (Fig. 2, lane 3), while 40W does not seem to
red in the second stage of the splicing contain much complementing activity (Fig. 2, lane 4). We
this, we have examined the effects of the also tested whether inactivated prpl8 extract could be com-
on in vitro mRNA splicing. Whole-cell plemented by micrococcal nuclease-treated wild-type ex-
capable of in vitro splicing were prepared tracts. Micrococcal nuclease treatment of wild-type extracts
ing the prpl8 mutation. Extracts from cells (SS330) caused a complete loss of splicing activity (data not
ermissive temperature were assayed for shown), as has been previously reported (7). Mixing the
at permissive temperature in vitro (15°C). treated wild-type extract and the inactivated prpl8 extract
vity was comparable with that of wild-type restored splicing activity (Fig. 2, lane 5). Therefore, comple-
,tstep of splicing seemed to be unaffected; mentation of inactivated prpl8 extracts does not require the
tent of the second reaction of splicing in presence of intact Ul, U2, U4, or U6 snRNAs, although the
-xtracts was variable (Fig. 1A; compare complementing activity resides in an snRNP-enriched frac-
8-2 strains ts503-la and ts503-6c). Hence, tion (40P3). However, since U5 snRNA is resistant to
,leavage at the 3' splice site and the ligation micrococcal nuclease and RNase H treatment (13), its re-
eared to be affected in whole-cell extracts quirement for complementation of inactivated prpl8 extracts
is mutant strain. cannot be judged.
the function of the PRP18 gene product, Isolation of heat-inactivated prpl8 spliceosomes and chasing
of extracts from the prpl8-2 strain (ts of the intermediates of splicing. It has been demonstrated by
ed out. Inactivation of extracts was done by various means that the first step of splicing takes place only
r 15 to 60 min at 30 to 32°C under the after the assembly of the spliceosome is complete (8, 17, 23,
ibed in Materials and Methods. The heat- 31). It is of interest to know whether components required
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FIG. 2. Complementation of heat-inactivated prpl8 extract.
prpl8 (ts 503-6c) extract, inactivated at 32°C for 70 min, was assayed
individually (lane 7) and in combination with either heat-inactivated
(A) prp5 extract (lane 1) or prpll (lane 2) or in combination with a
different inactivated prpl8 (ts 503-la) extract (lane 6). Combinations
ofprpl8 inactivated extracts and fractions of wild-type extract 40P3
(lane 3) or 40W (lane 4) or micrococcal nuclease-treated wild-type
extract (lane 5) were also assayed for complementation. After
mixing of extracts, the splicing reactions were initiated with the
addition of splicing cocktail and incubation at 15°C for 60 min. The
reaction intermediates and products are as described for Fig. 1A.
Heat-inactivated extracts are indicated (A). In each case, when
assayed individually, the inactivated mutant prpS orprpll extract or
the complementing wild-type fraction was completely devoid of
splicing activity (data not shown). The high-molecular-weight band
seen in lane 2 is due to some nonspecific aggregation at the origin of
the gel that was observed with some extracts.
for the second reaction can interact with preformed spliceo-
somes or whether they must interact early in spliceosome
assembly. We have isolated spliceosomes formed in prpl8
heat-inactivated extracts in order to investigate this ques-
tion.
Large-scale splicing reactions performed with heat-inacti-
vated prpl8 extract containing pre-mRNA, lariat intermedi-
ate, and exon 1 were sedimented through glycerol gradients,
and fractions were collected and counted (Fig. 3A). The
labeled pre-mRNA in the 40S and the 30S regions of the
gradient was monitored by electrophoresis on a denaturing
polyacrylamide gel. A peak of lariat intermediate, exon 1,
and pre-mRNA was observed in the 40S region of the
gradient. This indicates that the defective spliceosomes
remain reasonably intact and can be isolated by gradient
sedimentation. Upon addition of inactivated prpS or prpll
extracts or the ammonium sulfate fraction 40P3 to the
spliceosomal complexes in fraction 12, a conversion to
products was observed (Fig. 3B, lanes 1, 2, and 3). No
products were formed in the absence of complementing
extract (Fig. 3B, lane 7). The chasing of the spliceosomal
intermediates is not complete, implying some inefficiency in
complementation with assembled spliceosomes. Comple-
mentation of the inactivated spliceosome has a requirement
for ATP (Fig. 3B, lane 8). This experiment demonstrates the
requirement for ATP in the second step of the splicing
reaction.
The complementation to chase intermediates into prod-
ucts could be due to (i) chasing of the lariat intermediate and
exon 1 in the preformed complex, (ii) disassembly and
reassembly of splicing components in the spliceosome and
the complementing fraction, or (iii) the splicing of the
pre-mRNA in this region of the gradient. In all cases in
which chasing was observed, a decrease in the level of lariat
intermediate accompanied the appearance of intron and
mRNA. This supports our belief that chasing of the spliceo-
somal intermediates takes place. The second possibility has
been ruled out by the addition of a second transcript during
chasing reactions that, if spliced, would result in a different-
size mRNA. These chasing reactions did not result in any
mRNA production from the second transcript (data not
shown). We cannot rule out the possibility that pre-mRNAs
in assembled spliceosomes were also chased into products.
As with the complementation, chasing of splicing interme-
diates is obtained with micrococcal nuclease-treated crude
extracts or ammonium sulfate fraction 40P3 (Fig. 3B, lanes 4
and 5), again suggesting that neither complementation nor
chasing requires intact snRNPs. These experiments demon-
strate that PRP18 function is not needed for the formation of
spliceosomes but is required for the second step of splicing.
They further suggest that PRP18 can interact with the
preassembled spliceosome.
Isolation of the PRP18 gene. Molecular analysis of the
locus encoding the PRP18 gene product is essential for the
complete analysis of the role of this gene product in splicing.
The PRP18 gene was cloned on the basis of its ability to
complement the temperature-sensitive mutation. A prpl8
strain was transformed with a yeast genomic library con-
structed in a yeast centromere plasmid library and incubated
on selective plates at 23°C. The resulting URA transformant
colonies were replica plated to prewarmed rich plates (YPD)
at 37°C to select temperature-resistant colonies. Yeast plas-
mids were recovered from several of these colonies and
transferred to E. coli. The plasmids were propagated in E.
coli, and preliminary restriction mapping indicated that the
recombinant plasmids were related. Retransformation of the
prpl8 strain with these plasmids from the yeast library after
propagation in E. coli confirmed that the presence of the
clone confers temperature resistance. Transformation of the
yeast vector YCp5O did not confer wild-type growth. One of
the complementing plasmids (pUV18) was used in further
experiments.
Strains bearing the plasmid pUV18 were patched on
selective plates containing 5-fluoro-orotic acid to select for
the loss of centromere-containing plasmids from the trans-
formants. Ura colonies obtained by this method were tested
for temperature sensitivity and were found to have reverted
to the temperature-sensitive phenotype. Thus, the presence
of the plasmid alone conferred a wild-type phenotype.
Transformation of pUV18 into other prp strains did not
result in complementation of the temperature-sensitive phe-
notype. All of these results indicate that pUV18 carries the
PRP18 gene.
pUV18 contains a yeast genomic DNA fragment of about
7 kilobases (kb). A restriction map was generated. To define
the limits of the complementing sequence, specific restric-
tion fragments of the insert were subcloned into a yeast
low-copy-number (CEN) shuttle plasmid (pPHY18). Figure
4 shows that while plasmids pUV18-2, pUV18-4, and
pUV18-20 were capable of generating URA temperature-
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FIG. 3. (A) Chasing of heat-inactivated (A) prpl8 spliceosomes. The gradient profile of a 50-,ul splicing reaction conducted with inactivated
prpl8 extracts is shown. The reaction mixture was sedimented for 100 min and analyzed as described in Materials and Methods. Analysis of
the labeled RNA in a sample of the gradient fractions (data not shown) revealed a peak of lariat intermediate at fraction 12, corresponding
to the peak of 32P-labeled RNA in the 40S region of the gradient. (B) Complementation ofprpl8(A) spliceosomes. Fraction 12 from the gradient
described in panel A was used as the prpl8 heat-inactivated spliceosome. Chasing of the intermediates in the spliceosome was done as
described in Materials and Methods. No complementing extract was added in lane 7, lane 1 was incubated with inactivated prpll, lane 2 was
incubated with inactivated prpS, lane 3 was incubated with fraction 40P3 from wild-type extract, lane 4 was incubated with micrococcal
nuclease-treated 40P3, lane 5 was incubated with 40W fraction of wild-type extract, and lane 8 was incubated with inactivated prpll extract
in the absence of ATP in the chasing mix. The products of the chasing reaction, lariat intron (IVS*), and the spliced exons (mRNA) are
indicated in the figure. Other products are as indicated for Fig. 1A.
resistant colonies and complementing the prpl8 mutation
when transformed into prp18, plasmids pUV18-3, pUV18-
17, and pUV18-19 yielded URA colonies that were temper-
ature sensitive. These results imply that the complementing
sequence lies in the BamHI-to-NruI region of the genomic
fragment in pUV18. Subclone pUV18-20, which was capable
of complementing the temperature-sensitive phenotype, was
used in a second series of subcloning experiments, and
several restriction fragments were cloned into the CEN
vector pPHY18. These transformation experiments indi-
cated that the HindlIl site interrupts the complementing
sequence but left unclear whether the XhoI site lies within or
outside the complementing sequence (Fig. 4). The comple-
menting fragment (the region from BamHI to NruI) was also
cloned into a yeast multicopy vector (2,um, i.e., pSEY18) in
addition to the low-copy-number vectors described above.
The increased expression of this genomic fragment on this
plasmid again gave complete complementation.
Complementation of the mutant splicing phenotype. The
prpl8 strain accumulates lariat intermediates of splicing in
vivo at both permissive and nonpermissive temperatures
(41). We have confirmed that this phenotype is relieved by
the presence of the wild-type gene. Total RNA was prepared
from the original prpl8 strain, from the prpl8 strains trans-
formed with complementing plasmids (pUV18 and pUV18-
15), and from the strain transformed with the vector YCp5O.
The RNA was fractionated by electrophoresis on formal-
dehyde-agarose gels, blotted onto nylon membranes, and
probed with a labeled fragment of the actin intron. Figure
SA, lanes 7 and 8 show accumulation of the lariat interme-
diate of actin in the original prpl8 strain and in the prpl8
strain bearing only the YCp5O vector (lanes 1 and 2) at both
permissive and nonpermissive temperatures. No accumula-
tion of lariat intermediate took place in the strain containing
the original complementing clone pUV18 (Fig. 5, lanes 3 and
4) or the subclone pUV18-15 (lanes 5 and 6). In addition,
reverse transcription experiments using a primer comple-
mentary to the RP5JA intron 70 bases downstream of the 5'
splice site were done to detect lariat intermediates from the
RPSJA gene (for RPSJA sequence, see reference 39). These
experiments (Fig. SB) again confirmed that the levels of
lariat intermediate from the RPSA gene are reduced to the
wild-type levels (lane 1) in strains carrying pUV18 (Fig. 5B,
lanes 2, 3, and 4). The mutant strain showed high levels of
extension product corresponding to the lariat intermediate
from RPSJA (Fig. SB, lane 5).
Cloned DNA maps to the PRP18 locus. To prove that the
complementing clone obtained corresponds to the PRP18
gene and is not an extragenic suppressor capable of relieving
the Prp phenotype, integration of the cloned complementing
genomic DNA was performed. A complementing fragment
(the 5-kb EcoRI fragment from pUV18-4) was cloned into a
yeast integrating plasmid (YIP5). Directed integration of the
YIP5 subcloned DNA was accomplished by restricting the
DNA at the unique XhoI site in the genomic fragment (Fig.
6A). URA colonies were selected after transformation of the
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FIG. 4. In vivo complementation analysis with clones and subclones of PRP18. Restriction map of pUV18 and complementation
phenotype for the subclones with portions of the genomic DNA fragment in pUV18 are shown. Only restriction sites relevant to the isolation
of subclones and the generation of hybridization probes are indicated. Symbols: +, ability to suppress the temperature-sensitive growth defect
of prp18; -, inability to confer temperature insensitivity; -, YCp5O sequences; and M, complementing region. Restriction enzymes are
indicated as follows: B, BamHI; C, ClaI; E, EcoRI; H, Hindlll; N, NruI; S, SaII; and X, XhoI.
linear DNA into the wild-type SS330. The URA strains were
crossed to the temperature-sensitive ura prpl8 strain, and
diploids were selected for prototrophy. Sporulation of dip-
loids and dissection of spores from two diploid clones
demonstrated a cosegregation of the TS and URA phenotype
and of the temperature-sensitive and Ura phenotype in
several tetrads (14 from each diploid). This analysis shows
that the cloned DNA was integrated at the homologous
chromosomal PRP18 locus.
Southern analysis was also performed as a second means
of proving homologous recombination to the PRP18 locus.
Genomic DNA was isolated from the untransformed strains
SS330 and prp18, two SS330 URA integrative transformants,
and the diploid obtained from crossing the integrative trans-
formant with prpl8. All the genomic DNA preparations were
digested with the enzyme SalI. The DNA was then separated
by electrophoresis on agarose gels, blotted, and probed with
a fragment containing the entire complementing region.
Figure 6A diagrams the expected integration event to the
PRP18 locus. As expected, the probe detected only one SaIl
fragment (Fig. 6B) in the untransformed parental strains (the
PRP18 gene does not contain a SatI site). Each integration
event brings in one Sall site from the YIP5 vector se-
quences. Hence, as a result of integration the probe hybrid-
ized to two fragments in the haploid URA integrant SS330-Ib
(Fig. 6B). Three fragments were detected in the SS330
integrative transformant SS330-Ia (Fig. 6B), an event most
likely due to tandem insertion of two copies of the cloned
DNA. All of the integration, segregation, and Southern blot
analyses are consistent with our having cloned the wild-type
allele of PRP18.
DISCUSSION
Identification of a factor affecting late stages of splicing.
Biochemical fractionation of splicing extracts and analysis of
the assembly of the spliceosomes have indicated the impor-
tance of snRNP and protein factors in splicing (reviewed in
references 28 and 35). In the study of pre-mRNA splicing in
yeast, a combined genetic and biochemical approach has
been taken with the characterization of the PRP2 to PRPJJ
gene products (40, 42). We have recently reported the
generation of a bank of temperature-sensitive mutations,
which were screened for defects in pre-mRNA splicing (41).
One of the complementation groups with a novel splicing
phenotype displayed an accumulation, in vivo, of the lariat
intermediate. This phenotype resulted from a trans-acting
defect affecting splicing and thus provided a means for the
analysis of the components required specifically for the
second step of splicing. In this paper we have investigated
the role of the PRP18 gene product in vitro and have also
obtained some molecular information about the PRP18 gene.
Splicing extracts prepared from the mutant strain were
defective in the second splicing reaction and accumulated
the lariat intermediate and exon 1. This splicing defect after
heat inactivation of splicing extracts is the same as the in
vivo phenotype after a shift to a nonpermissive temperature
(41). The loss of activity for the 3' intron-exon cleavage and
exon ligation could result from specific inactivation of a
splicing component or may be explained as a nonspecific
effect. The second possibility has to be considered because
some loss of splicing activity is observed upon heating of
even wild-type extracts (26). However, this is unlikely for
three reasons. First, loss of splicing activity in wild-type
extracts, when observed, always diminishes total splicing
activity due to a decrease in both reactions of splicing.
Second, the in vitro loss of activity for the second step of
splicing, observed in prpl8 strains, can be complemented
with inactivated extracts from different mutant strains and
also with fractions of wild-type extracts. Restoration of
activity in these mixing experiments probably results from
the exchange of active components from each of the inacti-
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FIG. 5. (A) Complementation of lariat intermediate accumula-
tion phenotype of prpl8 strains. Total RNA (10 ,g in each case)
prepared from cultures at 23 or 37°C (indicated below the lanes) was
electrophoresed through a 1.2% formaldehyde-agarose gel, blotted,
and cross-linked to GeneScreen. The blot was then probed with a
labeled fragment of the actin intron. Lanes 1 and 2 were loaded with
RNA from a prpl8 strain transformed with the vector YCp50, lanes
3 and 4 were loaded with RNA from prpl8 transformed with the
complementing subclone pUV18, lanes 5 and 6 were loaded with
RNA from prpl8 transformed with complementing subclone
pUV18-15, and lanes 7 and 8 were loaded with RNA from the
untransformed prpl8 strain. The position of the actin lariat interme-
diate is indicated (IVS*E2). (B) Suppression of lariat intermediate
phenotype of RPSIA. Reverse transcription was done to map the 5'
end of RP51A transcripts. Total RNA (20 ,ug) was hybridized to an
RPSIA oligonucleotide complementary to sequences 70 nucleotides
downstream from the 5' splice site. The extension products were
separated on 8 M urea-109o acrylamide gels. RNA from untrans-
formed wild-type (lane 1) and prpl8 (lane 5) strains, the prpl8 strain
transformed with the complementing plasmid pUV18 (lane 2), the
prpl8 strain transformed with the subclone pUV18-15 (lane 3), and
the prpl8 strain transformed with a complementing multicopy
plasmid (lane 4) was used. The last lane (M) contains oligonucleotide
markers of 70, 55, and 35 nucleotides treated with kinase, as
indicated at right. The strong extension stop seen in ts 503 just above
the 70-nucleotide marker corresponds to a reverse transcription stop
at the 5' end of the accumulated lariat intermediate in the mutant
strain.
vated extracts. Third, the cloned PRP18 gene completely
suppresses the Prp18 phenotype. The results strongly imply
that the splicing defect in prpl8 results from a specific
inactivation of a splicing component.
Complementation of heat-inactivated prpl8 extracts indi-
cated that complementation could be achieved by the addi-
tion of wild-type fractions containing the PRP18 gene prod-
uct. Fractionation of wild-type extracts by ammonium
sulfate precipitation followed by heparin agarose chromatog-
FIG. 6. Integration of the cloned DNA to the homologous chro-
mosomal PRP18 locus. (A) Diagram of the expected integration
event. A 5-kb complementing EcoRI fragment (Fig. 4) subcloned in
YIP5 was linearized at the unique XhoI site and transformed in the
wild-type strain SS330. Symbols: =, chromosomal locus; M,
cloned yeast DNA. Plasmid sequences ( ) and markers in the
plasmid (Ap, ampicillin resistance; Tc, tetracycline resistance;
URA3, yeast marker gene) are indicated. Restriction sites are
represented by the notations as given in the legend to Fig. 4. (B)
Southern blot confirming integration event at the cloned genomic
locus. DNA from the wild-type, prpl8 strain, and two integrants
(SS330-Ia and -Ib) was digested with SalI and run on a L.wo agarose
gel, blotted, and probed with the 4.5-kb BamHI-to-EcoRI (Fig. 4)
complementing fragment.
raphy has already identified three fractions (I, II, and III),
necessary for splicing (7). Fractions I and II are together
capable of assembling spliceosomes and supporting the first
step of splicing. Fraction III is required for completion of
splicing in the presence of fractions I and II. Complementa-
tion of heat-inactivated prpl8 extracts is best achieved with
40P3 (fraction I) and not with 40W (fractions II and III). This
indicated to us that there exists a requirement for compo-
nents other than those present in fraction III for the com-
pletion of splicing in the heat-inactivated prpl8 extracts. The
strong complementation obtained with 40P3 (fraction I)
implied that the complementing component needed for prpl8
is enriched in wild-type fraction I.
PRP18 probably corresponds to one of the as yet uniden-
tified but previously hypothesized factors, cn. These factors,
required for the second step of pre-mRNA splicing, were
suggested from experiments in which prp2 heat-inactivated
spliceosomes were complemented with wild-type extract
fractions (23). In these studies chasing of heat-inactivated
prp2 spliceosomes containing only pre-mRNA with 40P3
(fraction I) resulted in completion of both splicing reactions,
while complementation of prp2 spliceosomes with 40W
(fractions II and III) resulted in accumulation of lariat
intermediate. These experiments indicated that some fac-
tor(s) other than those present in fraction III is required for
the second step of splicing, and it was deduced to be
enriched in 40P3 (fraction I). The complementation of heat-
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inactivated prpl8 extract by fraction I implies that PRP18 is
possibly one of the cn factors.
Fractionation of HeLa cell extracts has identified splicing
factors required for the second step of splicing (19). One
component (SF3) identified by complementation assays was
described as a heat-sensitive factor present in nuclear ex-
tracts. In a preliminary fractionation scheme, SF3 cofrac-
tionated with snRNP-containing fractions. The other com-
ponent required for the second step of splicing (SF4A) was
identified in fractions depleted in snRNPs. The role of SF3
and SF4A in splicing reactions is similar to that of PRP18.
Both SF3 and PRP18 are enriched in snRNP-enriched frac-
tions. These two factors may play an analogous role. To
know whether they are homologous will require further work
in both systems. Although PRP18 appears to be enriched in
an snRNA-enriched fraction, micrococcal nuclease-treated
wild-type extract or 40P3 (fraction I) retains complementing
activity. This suggests the dispensibility of intact Ul, U2,
U4, and U6 spliceosomal snRNAs. These results do not rule
out the possibility that PRP18 is a protein component of one
of these snRNP(s) or a dissociable part of a multicomponent
structure. However, PRP18 must be exchangeable with the
mutant protein even after assembly of the spliceosome. The
RNase H and micrococcal nuclease insensitivity of the
essential, spliceosomal snRNA U5 make it difficult to estab-
lish whether it must remain intact for complementation of
inactivated prpl8 extracts. A direct assessment of any
association of PRP18 with snRNAs will be possible with
antibodies raised against the PRP18 protein.
prpl8 spliceosomes an intermediate in the splicing pathway.
The in vitro complementation of heat-inactivated prpl8
extracts implies that splicing components can exchange. The
formation of the spliceosome takes place even after heat
inactivation, suggesting that the PRP18 function is dispens-
able for spliceosome formation. Experiments were designed
to test whether the lariat intermediate in the spliceosome
could be chased to products and thus to determine whether
these spliceosomes represent intermediates in splicing.
Chasing of the intermediates of splicing into product is
achieved, although inefficiently, in the presence of comple-
menting factors. A requirement for ATP was observed in the
complementation reaction.
Multiple roles for ATP in splicing have been observed for
the assembly of the spliceosome and for the first reaction of
splicing (8, 17, 23, 31). The requirement for ATP in the final
step of splicing, 3' cleavage, and exon ligation had not been
previously shown. We have demonstrated that ATP and a
complementing extract are required in order to chase the
intermediates in a prpl8 spliceosome into products. Since
the gradient fractions that contain the intermediates most
probably also have spliceosomes which contain pre-mRNA,
we cannot exclude the possibility that this assembled pre-
mRNA is also being chased into products. The correlation
between the appearance of mRNA and the decrease in the
lariat intermediate supports our belief that chasing of the
intermediates into products occurs. Recent experiments
with HeLa extracts have reported a requirement for ATP for
the second reaction of splicing (33). In these experiments,
the second splicing reaction was selectively inhibited, and
completion of splicing in such extracts occurred only in the
presence of ATP and additional nuclear extract. As in our
experiments, the isolated complex containing intermediates
could only form mRNA if ATP as well as extract was added.
These results taken together strongly suggest that ATP is
required for the second splicing step in both yeast and HeLa
systems. It will be very interesting to know what the
biochemical role of ATP is in this step and in any of the
several steps in which it is required.
Molecular analysis of PRP18. The temperature sensitivity
of the prpl8 mutation has allowed the cloning of the wild-
type gene, and this was essential for further analysis of the
role of PRP18 in splicing. The cloned gene in single-copy or
low-copy-number vectors (i.e., CEN vectors [YCp5O and
pPHY18]) is capable of rescuing the temperature-sensitive
phenotype and the in vitro splicing defect. The cloned DNA
has been characterized by restriction mapping and subclon-
ing; a -2.0-kb genomic fragment has been shown to com-
plement both phenotypes. This fragment is unique to the
yeast haploid genome. The cloned DNA has been shown to
be genetically linked to the PRP18 locus by integrative
transformation followed by segregation and Southern analy-
sis. These studies showed that the cloned DNA is the
wild-type PRP18 gene and not a suppressor of the tempera-
ture-sensitive and splicing phenotype. Transformation of the
cloned DNA on multicopy vectors does not alter the com-
plementation of phenotypes, and hence overexpression of
the protein-using yeast vectors would probably not be dele-
terious to the cell.
Further experiments to characterize this new yeast splic-
ing factor, including sequencing of the PPR18 gene, charac-
terization of the transcript, and analysis of the gene product,
are in progress.
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